Patients with
estrogen receptor (ER) α-negative
breast tumors have a poor prognosis and are not suitable for
hormone therapy. Previously, we demonstrated that
calcitriol, the active metabolite of
vitamin D, induces ERα expression and re-establishes the response to
antiestrogens in ER-negative
breast cancer cells. However, the mechanisms involved in this process have not been elucidated. Therefore, the present study was undertaken to investigate the mechanisms implicated in the
calcitriol-induced ERα expression in ER-negative
breast cancer cells. Using EMSA and ChIP assays, we found that the
calcitriol/
vitamin D receptor (VDR)/retinoic X receptor (RXR) complex binds to putative
vitamin D response elements (VDREs) in the ERα gene promoter region. In addition, we established by a fluorometric assay that
calcitriol decreased
DNA-
methyltransferase and
histone deacetylase activities. Flow cytometry and qPCR analyses showed that co-treatment of
calcitriol with inhibitors of the
histone deacetylase and
DNA methyltransferase, and
genistein significantly increased ERα expression, compared to that observed with the compounds alone. In conclusion, the
calcitriol-dependent ERα induction in ER-negative
breast cancer cells results from binding of the VDR-RXR complex to VDREs in the ERα gene promoter region, including the downregulation of
enzymes with chromatin-remodeling activities. These results may bring forth novel mechanistic knowledge into the actions of
calcitriol in ERα-negative
breast cancer.